News & Events
-
November 8, 2018
Profiles in Business with Tucson Metro Chamber
C-Path President and CEO Martha Brumfield, Ph.D., talks about today’s drug discovery process, C-Path’s global impact and what’s next for the organization on the Tucson Metro Chamber’s Profiles in Business podcast.
Listen Now.
-
November 5, 2018
Critical Path Institute Rebrands One of Its First Consortia to Highlight Focus on Alzheimer’s Disease
Critical Path for Alzheimer’s Disease (CPAD) consortium’s refined, refocused mission centers on accelerating therapy development for AD and related forms of dementia TUCSON, Ariz., November 5, 2018 — The Critical Path Institute (C-Path) is pleased to announce that its Critical Path for Alzheimer’s Disease (CPAD) consortium has refined and refocused its mission in celebration of... - November 1, 2018
-
November 1, 2018
C-Path, CHDI and CDISC Announce Therapeutic Area User Guide for Huntington’s Disease
TUCSON, Ariz., NEW YORK and AUSTIN, Texas, November 1, 2018 — The Huntington’s Disease Regulatory Science Consortium (HD-RSC), launched in March 2018 by the Critical Path Institute (C-Path) and CHDI Foundation, today, along with the Clinical Data Interchange Standards Consortium (CDISC), announce the open availability of a newly developed Huntington’s Disease Therapeutic Area User Guide... -
October 30, 2018
Free Webinar – SOT Clinical and Translational Toxicology Specialty Section (CTTSS): Acetaminophen Induced Liver Toxicity: Mechanisms, Diagnosis and Treatment
Members of C-Path’s Predictive Safety Testing Consortium (PSTC) are among the featured facilitators of a free webinar, sponsored and hosted by the Clinical and Translational Toxicology Specialty Section of the Society of Toxicology, on acetaminophen (APAP) induced liver toxicity. Join us online Tuesday, Oct. 30, from 1-2 p.m., EST., for a discussion of APAP-induced liver...
